SUMMARY -Waist circumference (WC), waist-to-hip ratio (WHR), and waist-to-height ratio (WHtR) are superior to body mass index (BMI) in predicting type 2 diabetes mellitus (T2DM) development. Th e aim of this study was to investigate the predictive power of BMI, WC, WHR and WHtR for microvascular (chronic kidney disease (CKD), retinopathy and peripheral neuropathy) prevalence in obese (BMI ≥35 kg/m 2 ) T2DM patients. Th is cross-sectional study included 125 T2DM patients of both genders. Th e validity of each test was assessed by Receiver Operating Characteristic (ROC) curves; the area under the curve (AUC) was calculated for each anthropometric parameter and microvascular complication. AUCs for WHtR were signifi cantly higher than AUCs for WC with respect to CKD. Optimal cut-off for WHtR was >0.593 and WC >112 cm regarding CKD. Th e AUC for peripheral neuropathy was signifi cant only for WHR and optimal cut-off for WHR was >1.409 with low sensitivity and high specifi city. Our study demonstrated that WHtR, WC and WHR might be used as simple and noninvasive methods for detection of CKD and peripheral neuropathy in obese T2DM population.
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Introduction
Obesity is considered to be the major risk factor for type 2 diabetes mellitus (T2DM) development, the estimated prevalence of which was 8.5% in Europe in 2013, while this population continues to develop diabetic macro-and microvascular complications resulting in increased disability and enormous healthcare costs 1, 2 . Several study reports suggest that fat distribution is important as a risk factor for T2DM development, i.e. anthropometric measurements that describe central or 'android fat' distribution are superior to general obesity measurements in predicting T2DM [3] [4] [5] [6] [7] .
Anthropometric measurements are commonly used to assess disease risk factors as they are easy to monitor at the community level, as well as in large epidemiologic studies in order to predict T2DM development 8 . Body mass index (BMI) relates weight to height and was most frequently used to estimate the prevalence of obesity within a population; while BMI ≥25 kg/m 2 is associated with increased T2DM morbidity, BMI ≥30 kg/m 2 is associated with an increased risk of morbidity and mortality from diabetes and its complications 9, 10 . However, BMI refl ects total body fat and does not distinguish diff erent patterns of fat distribution 11 . Waist circumference (WC) and waist-to-hip ratio (WHR) have been proposed as tools to detect central obesity but taking into consideration that WC might over-or under-evaluate the risk for tall or short individuals with similar WC and that WHR has a limitation in case of weight loss when both sizes decrease but changes in the ratio remain rather small 12 . Waist-toheight ratio (WHtR) is another anthropometric measurement of central obesity that corrects WC for height and is supported as an index that can be used in diff erent ethnic, age and sex groups for central obesity screening [13] [14] [15] . Th e relationship between metabolic control and development of microvascular complications (retinopathy, neuropathy and nephropathy) is a primary concern of clinicians. Factors involved in the development of vascular complications in diabetes include duration of diabetes, poor glycemic control, smoking, hypertension and dyslipidemia, but the role of body weight/ body fat distribution is unclear 16 . Th ere is a possible eff ect of BMI on retinopathy in diabetic patients, derived primarily from Diabetes Control and Complications Trial (DCCT) 17 , where BMI was observed to have a signifi cant predictive value in developing retinopathy besides the traditional factors, as later confi rmed by Henricsson et al. 18 . Only a few recent reports suggest a role of BMI in neuropathy development 19, 20 . However, there are several studies linking obesity to chronic kidney disease (CKD) in diabetic patients 21, 22 . Moreover, recent data suggest that central obesity might play a key role in associating obesity with the risk of microvascular complications, acting through several diff erent pathophysiological pathways [23] [24] [25] [26] . Th e aim of our study was to investigate the predictive power of BMI, WC, WHR and WHtR for the prevalence of microvascular complications (CKD, retinopathy and peripheral neuropathy) in obese (BMI ≥35 kg/m 2 ) T2DM patients.
Patients and Methods
Th is was a cross-sectional study including a sample of 125 T2DM consecutive patients of both genders presenting for complete annual check-up at our Clinic for Diabetes, Endocrinology and Metabolic Diseases. Patients with kidney (other than diabetic nephropathy) and liver disorders, psychiatric diseases, non-essential hypertension, or any chronic or acute infection were not included in the study. Th e study protocol complied with the Declaration of Helsinki, as well as with local institutional guidelines, and was approved by the local ethics committees. A written informed consent was obtained from all participants.
All subjects were studied in the morning between 07:00 and 08:30 AM after an overnight fast. Baseline anthropometric measurements were performed in all study subjects by the same physician. WC was measured on bare skin as the narrowest circumference between the 10 th rib and the iliac crest with tailor meter. Weight was measured by the physician using a balanced-beam scale with light clothing without shoes and expressed in kilograms (kg) and height was measured using a wall-mounted stadiometer and expressed in centimeters (cm) according to the Th ird National Health and Nutrition Examination Survey (NHANES III) study 27 . A steel tape measure was used to measure female WC, midway between the lower rib margin and the iliac crest, and hip circumference at the widest point between the iliac crest and buttock. Th e circumferences were measured in standing position and to the nearest 0.5 cm. BMI was calculated as weight in kilograms divided by the square of height in meters (kg/m 2 ). WHR and WHtR were calculated by dividing WC by hip circumference and body height, respectively.
Urine albumin excretion (UAE) was measured from at least two 24-h urine samples and determined as the mean of 24-h urine on two consecutive days to minimize variability. Serum creatinine was measured in fasting blood sample. Data on serum creatinine levels, age, sex and race were used to calculate the estimated glomerular fi ltration rate (eGFR) using the Chronic Kidney Disease Epidemiology Collaboration (CKD--EPI) formula to determine the presence of diabetic nephropathy 29 . CKD was defi ned as the presence of impaired eGFR (less than 60 mL/min -1
1.73m
-2 ) and/ or macroalbuminuria (UAE ≥300 mg/24 h). Retinopathy was diagnosed by binocular indirect slit lamp funduscopy and fundus photography after mydriasis with eye drops containing 0.5% tropicamide and 5% phenylephrine. Color fundus photographs of two fi elds of both eyes were taken with a suitable 45° fundus camera (VISUCAM, Zeiss, Germany) according to the EU-RODIAB retinal photography methodology 28 . In each patient, the 'worse' eye was graded for retinopathy using fundus photographs. Evaluation of peripheral neuropathy was based on clinical symptoms (neuropathy symptom score), signs (neuropathy disability score), quantitative sensory testing (vibration perception threshold), and electroneuromyography testing was performed to detect peripheral sensorimotor neuropathy.
Blood pressure was measured in the sitting position with a mercury sphygmomanometer with a cuff appropriate to the length and circumference of the arm after 10-min rest and expressed in mm Hg. Fasting venous blood samples were collected for determi nation of biochemistry panel, lipid profi le status and HbA1c. Serum cholesterol and triglycerides were measured by an enzymatic colorimetric method. HbA1c was measured spectrophotometrically by turbidimetric immuno-inhibition (Olympus AU600, Beckman-Coulter, USA).
Statistics
Baseline data on all patients were reported using descriptive statistics. Normality of distribution for continuous variables was analyzed using Shapiro-Wilk test. Normally distributed variables were described with mean and standard deviation (SD), while variables that were not normally distributed were described with median, minimum and maximum. Nominal variables were reported with absolute numbers and/or percentages. Th e validity of each test was assessed by the receiver operating characteristic (ROC) curves; the area under the curves (AUC) was calculated for each anthropometric parameter (BMI, WC, WHR and WHtR) and microvascular complication. Individual cutoff s, sensitivity and specifi city were estimated by Youden index. Diff erences between AUCs were tested with nonparametric test 30 . AUC indicates a measure of degree of separation between aff ected and nonaff ected subjects by a specifi c test and the value of 0.5 or lower indicates no discriminative value of the test used. Statistical interference is based on 95% confi dence interval (CI) and 5% P values. Statistical analysis was conducted using the Statistical Package for Social Sciences (SPSS) ver. 17.0 and MedCalc 12.0 for Windows.
Results
Out of 125 T2DM study patients, there were 65 (52%) male patients, median age 58 years with 11 years of disease duration. Table 1 summarizes descriptive anthropometric characteristics and biomedical data, as well as the prevalence of microvascular complications in all study subjects. Th e results of ROC analysis of the four anthropometric indices for three major microvascular complications (CKD, retinopathy and peripheral neuropathy) are shown in Table 2 . Th e AUC for WHtR was signifi cantly higher than the AUC for WC with respect to CKD. Th e AUC for peripheral neuropathy was signifi cant only for WHR. With regard to retinopathy, there was no signifi cant diff erence among the anthropometric parameters observed. Moreover, the AUCs suggested that these predictors should not be considered as validated tests. Table 3 shows optimal cutoff s and their sensitivity and specifi city for the parameters that showed validity according to AUCs. Optimal cutoff for WHtR was >0.593 
Discussion
In this study on a representative sample of obese T2DM adults, we demonstrated that WC and WHtR were superior to BMI and WHR, and that WHtR was better than WC in discriminatory power for identifying CKD, while WHR was superior to other estimates for identifi cation of peripheral neuropathy. Our study defi nitely supported the inconclusiveness of data on the relationship of BMI and microvascular complications [31] [32] [33] [34] [35] [36] [37] . It is known that anthropometric measurements of BMI, WHR and WC do not correlate entirely and are indices of diff erent aspects of obesity. For instance, adults with normal BMI may have markedly high anthropometric parameters of metabolic syndrome such as WC, sometimes referred to as metabolically obese normal-weight adults 38 . As discussed in the Introduction section, other anthropometric measurements of obesity also have limitations but have been proven to correlate more accurately with the amount of visceral adipose tissue 39, 40 . Although the exact pathophysiological pathway by which visceral adipose tissue acts in the development of microvascular complications remains to be exactly defi ned, there are several hypotheses that link it with hypertension and dyslipidemia, which are confi rmed to be among the major risk factors that cause vascular injury and some other homeostasis disorders which might enhance the eff ect of these two 16, 25, 39 . First, the hallmark of central obesity is insulin resistance and because insulin is considered to be an anti-infl ammatory hormone, insulin resistance might be considered as a proinfl ammatory state and visceral adipocytes and macrophages are also a source of proinfl ammatory cytokines 25 . Th e common knowledge suggests that they cause damage to endothelial cells and the process of atherogenesis in microcirculation begins. Second, several studies have indicated that central adipose tissue contributes to renin-angiotensinaldosterone system (RAAS) hormone disruption, i.e. increment in circulating levels of renin, angiotensinogen, angiotensin-converting enzyme, aldosterone, and angiotensin II 26 . Angiotensin II has been recognized as an important factor in raising intraglomerular pressure in the kidney and induction of intrarenal infl ammatory cytokines and growth factors which contribute to development and progression of hypertension. Th ere also are data indicating that angiotensin II contributes to cytokine production in visceral adipocytes, thus creating a circulus vitiosus in microvascular endothelium damage 24 . Dyslipidemia, defi ned as high total and lowdensity lipoprotein cholesterol and low high-density lipoprotein cholesterol with race and gender defi ned cut-off s, is a well-documented phenomenon in visceral obesity, the role of which is unavoidable in vascular atherogenesis and development of microvascular complications 41 . As discussed above, visceral fat is defi nitely involved in the pathogenesis of cardiometabolic risk factors and thus search for the best noninvasive measurements of visceral fat and their ability to predict cardiometabolic risk factors, development of diabetes and its chronic complications has recently come in the focus of interest worldwide. Th e majority of studies performed in healthy subjects and diabetic population have found that WC, WHR and WhtR in particular are correlated with the mentioned outcomes 3, 6, 7, 13, 15, 39, [42] [43] [44] [45] . We did not fi nd any signifi cance in retinopathy prediction among analyzed indices, and the possible explanation is that it is a complication that involves more factors than others, since the data published so far are most controversial of all 17, 18 . Th e possibility of anthropometric measurements to predict peripheral neuropathy has been poorly investigated, but the data published to date might be in concordance with our results, although they only indicate that these aspects of central obesity are associated with diabetic neuropathy 19 . Interestingly, similarly to our study results, Silva et al. 43 evaluated the precision of diff erent anthropometric measures of abdominal adiposity in non-diabetic non-dialyzed patients with CKD. Th ey assessed the accuracy of the following anthropometric indices: WC, WHR, conicity index and WHtR to assess abdominal adiposity and compared them using trunk fat by dual x-ray absorptiometry (DXA) as a reference method; they also explored their association with insulin resistance (IR) using homeostasis model assessment for IR index (HOMA-IR). Among studied indices, WHtR was the only one to show correlation with DXA trunk fat after adjusting for confounders and also indicated high HOMA-IR.
In conclusion, our study demonstrated that WHtR and WC might be used as simple and noninvasive methods for detection of CKD in obese T2DM population and we even may suggest using these indices as simple and inexpensive methods in epidemiological studies. On the other hand, WHR could correctly identify all patients without peripheral neuropathy with 100% specifi city. However, there is a limitation regarding this result considering the high prevalence of the disease in our study population. It is important to emphasize that our study had several other limitations, i.e. we did not make adjustments of the analyzed indices for the possible confounding factors that might contribute to development of microvascular complications, such as age, gender, diabetes duration or glycemic control, and we strongly suggest additional studies to determine whether there is true association between obesity indices and microvascular complications in T2DM patients and which of them could be used as a simple method for detection of a particular microvascular complication.
